AMAT: $342.94 ▲ 5.67 (1.68%)CAT: $694.12 ▼ -6.57 (-0.94%)JNJ: $243.38 ▲ 1.34 (0.55%)LRCX: $212.70 ▲ 3.21 (1.53%)MRK: $116.41 ▲ 0.50 (0.43%)MU: $421.29 ▲ 15.94 (3.93%)XOM: $155.73 ▲ 2.20 (1.43%)CRM: $192.59 ▼ -6.69 (-3.36%)IBM: $247.21 ▼ -0.47 (-0.19%)MSFT: $395.37 ▼ -6.49 (-1.61%)NFLX: $94.42 ▲ 0.11 (0.12%)ORCL: $156.55 ▼ -2.61 (-1.64%)PLTR: $151.15 ▼ -2.36 (-1.53%)AAL.L: $3,109.00 ▼ -144.00 (-4.43%)ASM.AS: $686.00 ▼ -21.80 (-3.08%)ASML.AS: $1,179.60 ▼ -0.80 (-0.07%)AZN.L: $14,380.00 ▲ 16.00 (0.11%)BAYN.DE: $38.64 ▼ -0.50 (-1.27%)ENGI.PA: $27.64 ▲ 0.28 (1.02%)ENR.DE: $143.95 ▼ -8.70 (-5.70%)GLEN.L: $518.40 ▼ -12.80 (-2.41%)HSBA.L: $1,180.40 ▼ -15.40 (-1.29%)NOVN.SW: $121.36 ▲ 0.52 (0.43%)RIO.L: $6,665.00 ▼ -180.00 (-2.63%)ROG.SW: $320.70 ▲ 2.50 (0.79%)RR.L: $1,215.50 ▼ -68.00 (-5.30%)RWE.DE: $57.02 ▲ 1.42 (2.55%)SU.PA: $248.00 ▼ -6.75 (-2.65%)TTE.PA: $72.33 ▲ 1.93 (2.74%)ULVR.L: $4,834.50 ▲ 7.00 (0.15%)NEM: $110.33 ▼ -4.15 (-3.63%)XAUUSD: $5,049.84 ▼ -29.42 (-0.58%)WDC: $274.02 ▲ 12.84 (4.92%)CVX: $195.98 ▼ -0.99 (-0.50%)INTC: $45.57 ▲ 0.32 (0.71%)LLY: $991.56 ▲ 14.31 (1.46%)WMT: $126.04 ▲ 0.71 (0.57%)ABBN.SW: $66.44 ▼ -1.28 (-1.89%)ALV.DE: $354.10 ▲ 3.60 (1.03%)BNP.PA: $84.89 ▼ -0.91 (-1.06%)ENEL.MI: $9.71 ▲ 0.22 (2.36%)GSK.L: $2,031.00 ▲ 4.00 (0.20%)NESN.SW: $80.87 ▲ 0.85 (1.06%)NG.L: $1,373.50 ▲ 5.50 (0.40%)SHELL.AS: $38.95 ▲ 0.41 (1.06%)SIE.DE: $220.35 ▼ -4.35 (-1.94%)AMGN: $367.18 ▼ -0.61 (-0.17%)COP: $121.26 ▲ 1.00 (0.83%)PEP: $160.25 ▲ 1.39 (0.87%)VZ: $51.47 ▲ 0.84 (1.66%)ABI.BR: $63.76 ▲ 1.14 (1.82%)TTE: $82.72 ▲ 1.30 (1.59%)COST: $1,006.21 ▲ 2.95 (0.29%)LIN: $497.23 ▲ 6.82 (1.39%)BA.L: $2,307.00 ▲ 9.00 (0.39%)DTE.DE: $33.33 ▲ 0.53 (1.62%)AAPL: $251.57 ▼ -4.19 (-1.64%)NVDA: $181.05 ▼ -2.11 (-1.15%)

Company Details

HeartBeam, Inc.

BEAT - NASDAQ

Identifiants & Marche

Ticker BEAT
ISIN US42238H1086
CIK 0001779372
Bourse NASDAQ
Devise USD

Classification

Secteur Healthcare

Entreprise

Pays US
Siege N/A
Fondee N/A
Site Web Lien

Description

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.